chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had 3 shots and still got them/suspected vaccination failure; Still got them; Had 3 shots; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis and Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 3rd dose of Shingles vaccine, the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had 3 shots and still got them/suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Still got them) and extra dose administered (Verbatim: Had 3 shots). The outcome of the vaccination failure and extra dose administered were unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine, Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 17-MAR-2023 This case was reported by a patient via interactive digital media. The patient had three shingles shots and still got shingles. The reporter stated that probably not as bad but still got shingles. This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The patient had three shingles shots, which led to extra dose administered. The follow up would not possible as no contact details were available.
Breakthrough case of COVID-19: I had a burning sore throat for two days, then I had a bad cold and fatigue for a week. It seemed to get better for a few days, then I develop a chest cough and post nasal drip. I went to the doctors and was prescribed an antibiotic for a sinus infection.
Body aches; Headache; She had a sore arm for 2-3 days which was very tender; This spontaneous case was reported by another health care professional and describes the occurrence of PAIN (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (She had a sore arm for 2-3 days which was very tender) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     The patient's past medical history included Anaphylaxis.    On 08-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In October 2021, the patient experienced PAIN (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (She had a sore arm for 2-3 days which was very tender). At the time of the report, PAIN (Body aches), HEADACHE (Headache) and VACCINATION SITE PAIN (She had a sore arm for 2-3 days which was very tender) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No Treatment information was reported.   This case was linked to MOD-2021-377173 (Patient Link).
Narrative: 05/19/2020 COVID swab, result: not detected 10/13/2020 COVID swab, result: not detected COVID infection following COVID vaccine series: 03/10, Pfizer, dose #1 03/31, Pfizer, dose #2 04/13 pt cc: elbows and forehead itchiness 07/20 pt cc: headache, confusion, lethargy, high blood pressure 07/21 TROPONIN I result: <0.016 07/21 COVID swab, result: not detected 07/21 CT Head impression: No acute intracranial abnormality07/21 CXR impression: NO acute intracranial abnormality. 07/21 ED admission for headache and dizziness 07/27 pt cc: chills, rhinorrhea, sore throat exposure: Birthday party 08/04 COVID swab, result: detected 08/04 COVID swab, result: detected 08/05 pt cc: chills and sore throat RESOLVED, rhinorrhea IMPROVING exposure: Birthday party 08/12 SARS-COV-2 LINEAGE AY.3 08/12 SARS-COV-2 CLADE 21A DELTA
they received first dose of GARDASIL in 2013 and second dose of GARDASIL in 2015; No additional adverse events reported.; This spontaneous report was received from a medical assistant and refers to a patient of an unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date in 2013 (at the age of 12 or 13 years old), the patient was vaccinated with the first dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On an unknown date in 2015, the patient was vaccinated with the second dose of quadrivalent human papillomavirus (types 6,11,16,18) recomb. vaccine (GARDASIL) (exact dose, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. Patient did not receive vaccine at recommended intervals per the prescribing information. No further information provided. No additional adverse events reported.
sore left upper arm (injection site); Chills; fever 103F; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left upper arm (injection site)), CHILLS (Chills) and PYREXIA (fever 103F) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included INTERFERON BETA-1B (BETASERON), VALSARTAN and LEVOTHYROXINE for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced VACCINATION SITE PAIN (sore left upper arm (injection site)), CHILLS (Chills) and PYREXIA (fever 103F). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 08-Mar-2021, CHILLS (Chills) and PYREXIA (fever 103F) had resolved. At the time of the report, VACCINATION SITE PAIN (sore left upper arm (injection site)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Body temperature: 103f (High) 103F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
SHOOTING PAIN IN MY NECK AND HEADACHE AND THE NEXT DAY I HAD CHILLS AND THE PAIN WAS KIND OF WORST. And the pain with my periods is really bad. I am getting lysergic and can't move and just lay down with the heat pad to keep it better. the doctors found some lumps on my ovaries and now the doctors are giving me birth control pill
Robotic assisted left total knee replacement. Hospital admission within 6 weeks of receiving the COVID vaccine.
Rash at injection site area - Erythema and induration at 10 cm X 10 cm at the (L) deltoid area. Warmth and mild tender to touch.
runny nose; allergy symptoms; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose) and HYPERSENSITIVITY (allergy symptoms) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00A2L1A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced RHINORRHOEA (runny nose) and HYPERSENSITIVITY (allergy symptoms). At the time of the report, RHINORRHOEA (runny nose) and HYPERSENSITIVITY (allergy symptoms) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient was reported to be taking using Zyrtec for her allergies before receiving the vaccine but stopped using Zyrtec as soon as she got the vaccine. No treatment medications were reported
24 y/o normally healthy male presents to the ED with c/o lip swelling which began a couple of mins after getting the Covid vaccination.  No throat swelling, trouble breathing, hives. Has a slight rash on bilateral shoulders he attributes to the detergent used on the apron he wears at work.  No other rash.
tired; rash from shoulder to elbow; Eyes heavy; feels under the weather; low energy level; slept for 3 days; This 81- year-old female patient contactable consumer received the second dose BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE lot EL9262), via an unspecified route of administration, on 28Jan2021 at 11:30 (at the age of 81-years-old) as a single dose for COVID-19 immunization, left arm in the muscle. The facility where COVID-19 vaccine was administered was at a clinic. Historical Vaccine included first dose of BNT162B2 on 07Jan2021 (lot EI3246), for COVID-19 immunization, left arm at the same site between 11:30-12:00.  The patient's concomitant medications included medications for years for thyroid and cholesterol. The medical history included: diagnosed allergies, compromised immune status, respiratory illness, genetic / chromosomal abnormalities, endocrine abnormalities (including diabetes) and obesity: Allergic to Sulfa, years ago and she got a rash. States she is very healthy. She has had no other vaccines in the past 4 weeks. She stated she has had a low energy level, heavy eyes (31Jan2021) and has been tired for nearly two weeks now. She still feels under the weather (31Jan2021). She had a rash from shoulder to elbow (31Jan2021) and was sleeping for 3 days(28Jan2021) without getting up much. For 3 days she was out and it got better, but she would go to bed (as reported) and back to bed. She is usually a very active person. Like yesterday, she had to go out. She is not one to fuss over anything. She went out and today, is a bit better. She is getting better every day. The outcome of the events low energy level and tired was unknown; rash, slept for 3 days, Eyes heavy, and feels under the weather was recovering.
-Dizziness/lightheadedness -Breathing difficulties  -Rapid heart beat -Feeling faint  -Developed a stiff neck on the left side   -Trapezius muscle spasm -Decreased range of motion -left shoulder
I became sick with COVID-19 two days after my husband had symptoms. It felt like a bad cold for about a week. I felt better but I had a lingering consistent cough. I had nasal congestion that also continued. I went to see my doctor after a month of persistent cough. The doctor told me I developed a sinus infection and an ear infection and put me on Augmentin. After six days of taking the Augmentin, the cough was gone and then I finished the ten-day course.
My water broke on 6/22/21 at 22 weeks and 6 days pregnant. I had my baby at 27 weeks and 4 days on 7/18/21. His estimated due date was 10/13/21.
The night of the shot severe pain and numbness at sight of injection. Lasted 3 days. Then on 4/2/21 woke  up with arm pain and at injection sight large red welt and itchy.  Did not go to the doctor.
Seizure  10/19/09 Emergency Department and Consultation Records eceived for dates of service 6/16/09- 10/8/09.  Dx:  Convulsions.  6/16/09:  Experienced a tonic clonic seizure while sleeping, 5 minutes of confusion in postictal period as well as wobbly legs.  ICD 9 Code: 780.39
Seen at ER for tingling RLE and RUE. Temp 99.1 131/88, 18, 114. Physical exam wnl.  Seen in follow-up 10-30-09: 99.3, 145/93, 20, 85.  Exam wnl, paresthesias resolved.
Sick for 36 hours. 102 degree fever, aches and chills. It felt as if I had the disease for 36 hours.
pt recvd vax 20AUG92 @ 12PM & 230PM became pale, clammy & cold skin; mom put pt in warm tub thinking was cold; no improvement noted; pt had crying episode of 30 minutes @ this time & was still pale; mom noted underactive; t101.5 w/APAP;
Woke up covered in hives, no difficulty breathing, no vomiting, no swelling on face.
The first Pfizer shot I was very fatigued and had sore, stiff muscles on my left side of body.  The second dose:  I did not experience fatigue or the soreness... however, I started itching about 6-7 after the injection.  The itching was in random places, but the itching was more like a pinch - it was sharper, but not long lasting.
COVID positive on 12/18/2021. Symptoms: cough, sore throat, fever, body aches, flem, general malaise
SORE ARM; BODY ACHES; HEADACHE; FEVER; NAUSEA; INCREASED FATIGUE; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (SORE ARM), MYALGIA (BODY ACHES), HEADACHE (HEADACHE), PYREXIA (FEVER) and NAUSEA (NAUSEA) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (SORE ARM), MYALGIA (BODY ACHES), HEADACHE (HEADACHE), PYREXIA (FEVER), NAUSEA (NAUSEA) and FATIGUE (INCREASED FATIGUE). At the time of the report, VACCINATION SITE PAIN (SORE ARM), MYALGIA (BODY ACHES), HEADACHE (HEADACHE), PYREXIA (FEVER), NAUSEA (NAUSEA) and FATIGUE (INCREASED FATIGUE) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medication reported Treatment medication was not provided by the reporter
Patient and guardian confirmed DOB and stated his age as 18 years old. Patient did not present his ID. We will implement a strategy of showing a birth certificate if photo ID is not readily available.
Had unconsolable crying & screaming for approx 4 hrs /p DTP spoke of pt's MD, stated to continue using Tylenol & to call if became abnormally sleepy or high T.
This spontaneous report has been received from a Registered Nurse refers to an adult patient of unknown age and gender. The patient's concurrent conditions and pertinent medical history were not reported. On 26-AUG-2015, the patient was inadvertently vaccinated with a pediatric dose of RECOMBIVAX HB, (strength, route of administration and dose were not provided), instead of an adult dose. No adverse effects were reported. A product quality complaint was not involved. Additional information is not expected as the reporter did not want to be contacted.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 13-DEC-2022, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
This case involves adult female patient who experienced double pneumonia after receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed serious double pneumonia (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment for the event.  At time of reporting, the outcome was unknown for the events.  There will be no information available on the batch number for this case.; Sender's Comments: This case concerns adult female patient who had pneumonia after receiving INFLUENZA VACCINE (Unknown manufacturer). The time to onset is unknown. Furthermore, information regarding medical history, past medical treatment(s), vaccination(s), concomitant medications, condition at the time of vaccination and laboratory data excluding other predisposing etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of vaccine cannot be assessed.
Patient reported to another nurse dizziness and feeling faint.  VS obtained  bp 141/90 pulse 88 o2 saturation 98% RA.  Upon writers assessment patient denied shortness of breath, tongue tingling or swelling.  She denies rash.  Patient able to walk, gait steady.  Declined further medical attention offered by writer.  Patient waited 30+ minutes before leaving vaccination site stating "I am fine."
ON DAY 1, PATIENT REPORTED HAVING AN ITCHY CHEST WITH NO RASH PRESENT. ON DAY 2, THE PATIENT REPORTED HAVING DIARRHEA, CHILLS AND SWEATS.
My blood pressure is always good but after the shot on Friday, the following Sunday and Monday it went up and stayed up for these 2 days and then got back to normal.
Had flu mist x 9 days ago.  Was seen in UCC on 09 Dec with HA, no temperature, sore throat, any + post nasal drip.  Given Atarak + qtr 2 yo.
The morning after, he had headaches, body aches, extreme fatigue which lasted almost all day. Wednesday, he's feeling about 100% better
This is a spontaneous report from a contactable physician via a Company representative. A 18 year-old male patient of an unspecified race and ethnicity received the first single dose of TRUMENBA via an unspecified route of administration on an unspecified date for immunization. The patient medical history and concomitant medications were not reported. The patient experienced flu like symptoms and dizziness on an unspecified date and went to the hospital. He was then fine. The patient then received the second single dose of meningococcal group b rlp2086 for immunization after the required period and then experienced again flu like symptoms (milder) but no dizziness and called the office. The patient was then fine. Sender's Comments: The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, as appropriate. The case will be reassessed if additional information becomes available.
J18.9 - Pneumonia, unspecified organism N17.9 - Acute kidney failure, unspecified D69.6 - Thrombocytopenia, unspecified
This spontaneous report was received from an 82 year old male patient referring to himself. Pertinent medical history included chronic idiopathic urticaria. The patient had no drug reactions/allergies. Concomitant therapies included omalizumab (XOLAIR) (reported as "XOLAR"). In approximately 2000 (reported as 18 years ago), the patient was vaccinated with PNEUMOVAX 23 (1 injection, strength and lot unknown, route reported as injection in the arm) to avoid pneumonia. In approximately 2007 (reported as 11 years ago), the patient contracted pneumonia which was confirmed by a chest X-Rays and was given antibiotics but was not getting better. The patient was hospitalized for 24 hours observation and given a higher dose of antibiotics intravenously and then treated as an outpatient and recovered. The patient said 2 years ago (in approximately 2016), he received PREVNAR 13. On an unknown date in January 2018 (also reported as this winter), the patient developed pneumonia in the right lung, and developed pneumonia in his left lung in April. He was treated with unspecified "cephalosporin and an azithromycin (Z-PAK) (reported as "Z-PACK")" and said he was recovered after completing a treatment. The causality assessment was not provided. Upon internal review, the event of pneumonia was determined to be medically significant.
Patient began to experience itching on her palms the next morning. Itching lessened and became more of a tingling sensation over the next day or so. As of 2/17/2023, patient states problem has "mostly" resolved.
Patient called clinic with concern of 1.5 in dia. redness around injection site and some soreness.  Will monitor site, apply ice and OTC ibuprofen. Will contact clinic for appointment if not improving.
after vaccination client had a weird taste in back of throat during 15 minute wait time. Had client wait additional  15 minutes and still had a weird taste in mouth.
This 40 year old woman was admitted with diarrhea.  She was found to have campylobacter enteritis.  She was treated with antibiotics and diarrhea has resolved.      she also had covid and was treated with remdesivir.  She is not hypoxic and her lungs are clear   She did have an elevated troponin on admission and was seen by cardiology.   This was felt to be type 2 MI.  Echo showed normal LVEF   She did have some agitation.  She denied alcohol use but coworkers and her mother told staff that she did .  She did improve with prn meds and has not required anything since bedtime last night.
pt recv vax 8AUG97 & same day pt devel dizziness, n/v & a severe h/a;pt was not hosp& a hosp discharge summary is not available;pt treated for event w/advil as needed;
I was very tired a few hours after the shot so went to bed a little early.  Shortly after, I experienced sharp heart pains (this sometimes happens with my mitral valve prolapse). The sharp pain went up the left side of my neck (not normal with my MVP). The insides of my thighs felt tingly, not painful but not painless either. It almost felt like they were on the verge of throbbing. I?ve never had this before so it?s hard to describe.